Publication

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Nature Metabolism 2(5):413–431, 2020

Boland ML, Laker RC, Mather K, Nawrocki A, Oldham S, Boland BB, Lewis H, Conway J, Naylor J, Guionaud S, Feigh M, Veidal SS, Lantier L, McGuinness OP, Grimsby J, Rondinone CM, Jermutus L, Larsen MR, Trevaskis JL, Rhodes CJ

View publication

Subjects
DIO mouseTherapeutic AreaMouseTargetCompoundMethod/EndpointSpeciesAMLN DIO-MASH mouseBody weightAMLN ob/ob-MASH mouseBlood biochemistryMetabolic dysfunction-associated steatohepatitisCotadutideGLP-1 receptorGlucagon receptorHistopathology scoreIntraperitoneal glucose tolerance test (IPGTT)Image analysisLiver biopsyLiver morphometryReal-time food intake/activity analysisLiraglutideObeticholic acid

Share this page

Resource Library

Related resources
Publication
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Publication
Activation of adenosine monophosphate-activated protein kinase reduces the onset of diet-induced hepatocellular carcinoma in mice
Publication
Hepatoprotective effects of the long-acting FGF21 analogue PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Poster
Metabolic, biochemical and histological effects of INT-767 in the GAN diet-induced and biopsy-confirmed ob/ob mouse model of NASH

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top